Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ras suppressor protein 1 pseudogene 2 (RSU1P2) is a non-protein-coding pseudogene and a long non-coding RNA (lncRNA), homologous to the functional Ras suppressor protein 1 (RSU1)[1][2]. Unlike its parent gene, RSU1P2 does not encode a functional protein but is transcribed as an lncRNA. It acts as a competing endogenous RNA, especially by sequestering tumor-suppressing microRNAs such as let-7a, preventing them from inhibiting their mRNA targets. This activity promotes the expression of oncogenic genes like IGF1R, N-myc, and EphA4, contributing to enhanced proliferation, migration, and invasion of cancer cells, particularly in cervical cancer[1]. Current research treats RSU1P2 primarily as a regulatory lncRNA with an oncogenic role via RNA-mediated mechanisms rather than as a traditional drug target (such as a receptor or enzyme)[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ras suppressor protein 1 pseudogene 2 (RSU1P2).